GSK receives Breakthrough Therapy Designation from FDA for meningitis B vaccine Bexsero

Read more

FDA approves Gilead’s Biktarvy for Treatment of HIV-1 Infection

Read more

60° Pharmaceuticals (60P) receives priority review designation for Malaria Drug

Read more

Concept Life Sciences expands GXP compliance

Read more

Novo Nordisk Launches Rebinyn in the United States for People with Hemophilia B

Read more

Sosei Provides an Update on Its Immuno-Oncology Clinical Program with AstraZeneca

Read more

Selvita appoints Steffen Heeger as Chief Medical Officer

Read more

Major research project launched to crack aspirin’s anti-cancer properties

Read more

Roivant Sciences and ArQule enter into License Agreement for Derazantinib in China

Read more

Xcovery initiates Phase 2 Clinical Trial for Ensartinib in Melanoma Patients with ALK Alternations

Read more